Beranda › Hemofilia B › Texas › Houston
Uji klinis Hemofilia B di Houston, TX
4 studi untuk Hemofilia B mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Menerima pesertaFase 1/2
- University of Texas Health Science Center at Houston, Houston
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
Menerima pesertaFase 3
- The University of Texas Health Science Center at Houston, Houston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Menerima pesertaStudi observasional
- Gulf States Hemophilia and Thrombophilia Center, Houston
- Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Menerima pesertaFase 4
- Gulf States Hemophilia and Thrombophilia Center-University of Texas Health Science Center @Houston, Houston
Uji klinis Hemofilia B di kota lain
- Philadelphia, PA5 studi
- Sacramento, CA4 studi
- Atlanta, GA4 studi
- Ann Arbor, MI4 studi
- Los Angeles, CA4 studi
- Seattle, WA3 studi
- San Francisco, CA3 studi
- Indianapolis, IN3 studi
- Gainesville, FL3 studi
- Nashville, TN3 studi
- Greenville, NC3 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.